2014年1月8日 · Objectives: Coupled plasma filtration adsorption (CPFA, Bellco, Italy), to remove inflammatory mediators from blood, has been proposed as a novel treatment for septic shock. …

CPFA is an extracorporeal treatment used in severe sepsis to remove circulating proinflammatory cytokines. Limited evidence exists on the effectiveness of bilirubin adsorption by the …

2020年2月1日 · CPFA was always carried out by using a polyethersulfone plasma filter (0.5 m 2, MPS 05, Bellco) placed in series with a highly permeable polyethersulfone hemodialyzer (1.4 …

Coupled plasma filtration adsorption (CPFA, Bellco, Italy), to remove inflammatory mediators from blood, has been proposed as a novel treatment for septic shock. This multicenter, randomised, …

CPFA® is an extracorporeal therapy that Bellco developed and patented for the treatment of patients with multi-organ failure (MOF) or sepsis. At present, sepsis is considered the result of …

2014年1月8日 · Coupled plasma filtration adsorption (CPFA, Bellco, Italy), to remove inflammatory mediators from blood, has been proposed as a novel treatment for septic...

CPFA®is an extracorporeal therapy that was developed and patented by Bellco for the treatment of sepsis. Lynda® (Bellco acute machine) is the technologic response suited to the treatments …

CPFA was performed with a polyethersulfone plasmafilter (0.7 m2, MPS 07, Bellco) placed in series with a highly permeable polysulfone hemodialyzer (1.2 m 2 , BLS627, Bellco). …

2025年1月13日 · Garbero等人汇报了一项针对脓毒性休克成人患者使用CPFA的多中心随机对照试验(COMPACT-2)。CPFA目标剂量为0.2L/kg血浆置换，每日10h左右。CPFA在休克诊断 …

Delivers treatments involving continuous renal replacement therapy (CRRT), intermittent renal replacement therapy (IRRT), plasma adsorption (CPFA), plasmapheresis with reinfusion of …